Cybin Company Presentation

Non-psychedelic medicinal mushroom nutraceutical products targeting the millennial generation with over 20 custom developed formulations and unique form factors. (1) We plan to sell consumer package goods (“ CPGs ”) in the natural health products, nutraceuticals or similar product categories that include a microdose of psilocybin in each dosage form. The CPGs will be sold in clinics or in retail environments where permitted by applicable law. (1) We plan to sponsor and conduct clinical studies and clinical trials studying the use of drug products that include psilocybin as an active pharmaceutical ingredient for the treatment of major depressive disorder. We plan to protect the drug products with patent applications. We will commercialize the drug products by selling the drug products or licensing intellectual property rights for manufacture and sale of the drug products to a third party . (1) Operating Divisions 5 P r i v a t e & C o n f i d e n t i a l Serenity Life Science Inc., a wholly-owned subsidiary of Cybin Corp. Natures Journey Inc., a wholly-owned subsidiary of Cybin Corp. Psychedelic (Psilocybin) Non-Psychedelic Pharmaceutical Psychedelics Nutraceutical Psychedelics Medicinal Mushrooms (1)Forward-looking statements are subject to various risks and assumptions. See “Cautionary Statement Regarding Forward-Looking Information” on page 2 of this presentation. (2) Packaging is conceptual and may not adhere to requirements of applicable legislation of certain territories (2) (2) (2)